Development of RP-HPLC methods for the analysis of Dexamethasone and Levofloxacin alone and in combinations used in the therapy of Covid-19


	Levofloxacin. (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid.

Part of: Peikova L, Tzankova D, Smerikarova M, Balkanski S, Zlatkov A (2022) Development of RP-HPLC methods for the analysis of Dexamethasone and Levofloxacin alone and in combinations used in the therapy of Covid-19. Pharmacia 69(4): 1075-1080. https://doi.org/10.3897/pharmacia.69.e97779